abbr. SJ GMU
ISSN 2657-5841 (printed)
ISSN 2657-6988 (online)
The Properties of Polyurethanes Based on Synthetic Polyhydroxybutyrate for Medical Application
Polyurethanes belong to materials commonly used in many different fields of our life. Very important part of their application is using as biomaterial. But their properties have to be appropriate for contact with living organisms. Using in synthesis of polyurethanes the synthetic analog of natural polyhydroxybutyrate - telechelic atactic poly[(R,S)-3-hydroxybutyrate] (a-PHB) could make them more biocompatible. The investigated polyurethanes were synthesized with aliphatic and aromatic diisocyanate. Their soft segments were built with polycaprolactone and a-PHB. The physical, mechanical, thermal properties and degradability of obtained polyurethanes were estimated. The polyurethane samples were also checked for medical application. After the extraction in hexane and sterilization their influence on blood parameters and on pathogenic microorganisms were estimated. The obtained polyurethanes were amorphous and hydrophilic but the amount of absorbed water was small and is on the same level for both materials. Sterilization of aliphatic polyurethane samples insignificantly changed the mechanical properties whereas aromatic polyurethane seemed to be more sensitive to conditions of sterilization. The results of polyurethane degradation indicated higher influence of oxidative than hydrolytic mechanism. The presence of aliphatic polyurethane decreased the growth of some pathogenic microorganisms. Both kinds of polymers did not change the parameters of whole blood. In conclusion it could be stated that aliphatic polyurethane based on atactic poly[(R,S)-3-hydroxybutyrate] displayed the properties appropriate for further investigations for medical application without the risk of generation the cancerogenic degradation products which could be formed from polyurethane obtained with aromatic diisocyanate.
Brzeska J., Dacko P., Janeczek H., Kowalczuk M., Janik H., Rutkowska M., 2011, “Influence of synthetic polyhydroxybutyrate on selected properties of novel polyurethanes for medicine, Part II, Polyurethanes based on aliphatic diisocyanate in hard segments”, Polimery 1:27–34.
Brzeska J., Janik H., Kowalczuk M., Rutkowska M., 2011 A, “Preliminary investigations of biocompatibility of polyurethanes based on synthetic polyhydroxybutyrate”, Engineering of Biomaterials, 106-108, vol. XIV: 65–72.
Brzeska J., Janik H., Kowalczuk M., Rutkowska M., 2011 B, “Influence of polyurethanes based on synthetic poly([R,S]-3-hydroxybutyrate) on microorganisms growth”, Engineering of Biomaterials, 106-108, vol. XIV: 73–78.
Brzeska J., Dacko P., Janeczek H., Kowalczuk M., Janik H., Rutkowska M., 2010, “Influence of synthetic polyhydroxybutyrate on selected properties of novel polyurethanes for medicine, Part I, Polyurethanes based on aromatic diisocyanate in hard segments”, Polimery, 1:44–47.
Chan-Chan LH., Solis-Correa R., Vargas-Coronado R.F., Cervantes-Uc J.M., Cauich- -Rodríguez J.V., Quintana P., Bartolo-Pérez P., 2006, “Degradation studies on segmented polyurethanes prepared with HMDI, PCL and different chain extenders”, Acta Biomaterialia, 6:2035–44.
Christenson E.M., Patel S., Anderson J.M., Hiltner A., 2006, “Enzymatic degradation of poly(ether urethane) and poly(carbonate urethane) by cholesterol esterase”, Biomaterials, 27: 3920–3926.
Defoirdt T., Boon N., Sorgeloos P., Verstraete W., Bossier P., 2009, ”Short-chain fatty acids and poly-ß-hydroxyalkanoates: (New) Biocontrol agents for a sustainable animal production”, Biotechnology Advances, 27:680–85.
Feng Y., Li Ch., 2006, “Study on oxidative degradation behaviors of polyesterurethane network”, Polymer Degradation and Stability, 91:1711–16.
Gaymans R.J., 2011, “Segmented copolymers with monodisperse crystallizable hard segments: Novel semi-crystalline materials.” Progress in Polymer Science 36:713–48.
Glarner M., Gogolewski S., 2007, “Degradation and calcification in vitro of new bioresorbable terpolymers of lactides with an improved degradation pattern”, Polymer Degradation and Stability, 9:310.
Gogolewski S., 1989, “Selected topics in biomedical polyurethanes. A review”, Colloid & Polym Sci, 267:757–85.
Gorna K., Gogolewski S., 2002, “In vitro degradation of novel medical biodegradable aliphatic polyurethanes based on ?-caprolactone and Pluronics® with various hydrophilicities”, Polymer Degradation and Stability, 75:113–22.
Guelcher S.A., 2007, “Biodegradable Polyurethanes: Synthesis and Applications in Regenerative Medicine”, Tissue Engineering, 1:3–17.
Kébir N. et al., “Use of telechelic cis-1,4-polyisoprene cationomers in the synthesis of antibacterial ionic polyurethanes and copolyurethanes bering ammonium groups”, Biomaterials, 28 (2007): 4200–4208.
Masiulanis B., Brzeska J., Tercjak A., 2000, “Polyurethane elastomers from cycloaliphatic diisocyanate and polyols with participation of castor oil”, Elastomery, 4:3–12.
Piddubniak V., Kurcok P., Matuszowicz A., Głowala M., Fiszer-Kierzkowska A., Jedliński Z., Juzwa M., Krawczyk Z., 2004, “Oligo-3-hydroxybutyrates as potential carriers for drug delivery”, Biomaterials, 25:5271–5279.
Polish Pharmacopeia, VI (2002).
Resiak I., Rokicki G., 2000, „Modyfikowane poliuretany do zastosowań medycznych”, Polimery, 9:592–602.
Santerre J.P., Woodhouse K., Laroche G., Labow R.S., 2005, “Understanding the biodegradation of polyurethanes: From classical implants to tissue engineering materials”, Biomaterials, 26:7457–70.